India, Feb. 17 -- Rx Propellant, India's leading science and R&D infrastructure platform established by Actis, has announced an investment of $100 million to develop a new, large-format life sciences campus in Genome Valley, Hyderabad as part of its long-term commitment to strengthening India's life sciences ecosystem.

The project will comprise development of more than 1 million square feet of advanced laboratory infrastructure to be delivered in phases over the next six years.

Planned as a single, integrated campus with multiple blocks, the project will be the largest life sciences campus in Genome Valley designed for corporations looking to lease buildings with well-managed resilient support infrastructure.

The campus will cater to I...